The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 Pandemic

被引：0
|
作者：
G. G. Onishchenko
T. E. Sizikova
V. N. Lebedev
S. V. Borisevich
机构：
[1] Sechenov First Moscow State Medical University (Sechenov University),
[2] Ministry of Health of the Russian Federation,undefined
[3] 48th Central Research Institute,undefined
[4] Ministry of Defense of the Russian Federation,undefined
来源：
Herald of the Russian Academy of Sciences | 2022年 / 92卷
关键词：
COVID-19; SARS-CoV-2 virus; Omicron variant; mutations; epidemiological characteristics of disease; vaccination; medical protective means; preventive and curative efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 391
页数：10
相关论文
共 50 条
  • [31] SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine
    Mostafavi, Ebrahim
    Dubey, Ankit Kumar
    Teodori, Laura
    Ramakrishna, Seeram
    Kaushik, Ajeet
    MEDCOMM, 2022, 3 (01):
  • [32] Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic
    Martin, Javier
    Klapsa, Dimitra
    Wilton, Thomas
    Zambon, Maria
    Bentley, Emma
    Bujaki, Erika
    Fritzsche, Martin
    Mate, Ryan
    Majumdar, Manasi
    VIRUSES-BASEL, 2020, 12 (10):
  • [33] Bacterial coinfections in hospitalized children with COVID-19 during the SARS-CoV-2 Omicron BA.2 variant pandemic in Taiwan
    Lai, Huan-Cheng
    Hsu, Yu-Lung
    Lin, Chien-Heng
    Wei, Hsiu-Mei
    Chen, Jiun-An
    Low, Yan-Yi
    Chiu, Yu-Ting
    Lin, Hsiao-Chuan
    Hwang, Kao-Pin
    FRONTIERS IN MEDICINE, 2023, 10
  • [34] SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Van Vo, Giau
    Bagyinszky, Eva
    Park, Yoon Soo
    Hulme, John
    An, Seong Soo A.
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 3 - 19
  • [35] New variant of SARS-CoV-2 in UK causes surge of COVID-19
    Kirby, Tony
    LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : E20 - E21
  • [36] Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway
    STALCRANTZ, J. E. A. N. E. T. T. E.
    KRISTOFFERSEN, A. N. J. A. B. R. A. T. H. E. N.
    BOAS, H. A. K. O. N.
    VENETI, L. A. M. P. R. I. N. I.
    SEPPALA, E. L. I. N. A.
    AASAND, N. I. N. A.
    HUNGNES, O. L. A., V
    KVALE, R. E. I. D. A. R.
    BRAGSTAD, K. A. R. O. L. I. N. E.
    BUANES, E. I. R. I. K. A. L. N. E. S.
    WHITTAKER, R. O. B. E. R. T.
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2022, 50 (06) : 676 - 682
  • [37] The murky origins of the coronavirus SARS-CoV-2, the causative agent of the COVID-19 pandemic
    Balaram, P.
    Current Science, 2020, 120 (11): : 1663 - 1666
  • [38] SARS-CoV-2 New Virus Variant is more infectious, but does not change the Course of COVID-19
    Meyer, Ruediger
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (31-32): : A1505 - A1505
  • [39] A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
    Al-Awwal, Nasruddeen
    Dweik, Ferris
    Mahdi, Samira
    El-Dweik, Majed
    Anderson, Stephen H.
    PATHOGENS, 2022, 11 (03):
  • [40] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
    Mattiuzzi, Camilla
    Henry, Brandon M.
    Lippi, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168
12345